Reversal of rocuronium induced neuromuscular block with sugammadex or neostigmine: A large observational study

Acta Anaesthesiologica Scandinavica

Volumn 57, Issue 9, 2013, Pages 1138-1145

  Della Rocca, G ^a   Pompei, L ^a   Pagan De Paganis, C ^b   Tesoro, S ^c   Mendola, C ^d   Boninsegni, P ^e   Tempia, A ^f   Manstretta, S ^g   Zamidei, L ^h   Gratarola, A ⁱ   Murabito, P ^j   Fuggiano, L ^k   Di Marco, P ^l  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d Azienda Ospedaliera Universitaria Maggiore Della Carita   (Italy)

^e UNIVERSITY OF FLORENCE   (Italy)

^f Azienda Ospedaliera Universitaria S Luigi   (Italy)

^g FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^h Hospital Misericordia a Dolce Prato   (Italy)

ⁱ UNIVERSITY OF GENOA   (Italy)

^j UNIVERSITY OF CATANIA   (Italy)

^k VITO FAZZI HOSPITAL   (Italy)

^l SAPIENZA UNIVERSITY OF ROME   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; DESFLURANE; NEOSTIGMINE; PROPOFOL; ROCURONIUM; SEVOFLURANE; SUGAMMADEX;

ADULT; AGED; ANALGESIA; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROMUSCULAR BLOCKING; OBSERVATIONAL STUDY; PEROPERATIVE CARE; PRIORITY JOURNAL; RECOVERY ROOM;

ABDOMEN; ADULT; AGED; AIRWAY EXTUBATION; ANALGESICS, OPIOID; ANDROSTANOLS; ANESTHESIA RECOVERY PERIOD; ANESTHESIA, GENERAL; ENDPOINT DETERMINATION; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; MALE; MIDDLE AGED; MOVEMENT; NEOSTIGMINE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PARASYMPATHOMIMETICS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RECOVERY ROOM; SAMPLE SIZE;

EID: 84884282111     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/aas.12155     Document Type: Article

References (26)

1. Suresh D, Carter JA, Whitehead JP, Goldhill DR, Flynn PJ,. Cardiovascular changes at antagonism of atracurium. Effects of different doses of premixed neostigmine and glucopyrronium in a ratio of 5:1. Anaesthesia 1991; 46: 877-880.
2. Caldwell JE,. Reversal of residual neuromuscular block with neostigmine at one to four hour after a single intubating dose of vecuronium. Anesth Analg 1995; 80: 1168-1174.
3. Feinberg M,. The problems of anticholinergic adverse effects in older patients. Drugs & Aging 1993; 3: 335-348.
4. Bom A, Bradley M, Cameron K, Clark JK, Van Egmond J, Feilden H, MacLean EJ, Muir AW, Palin R, Rees DC, Zhang MQ,. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl 2002; 41: 266-270, 276.
5. Arbous MS, Meursing AE, van Kleef JW, de Lange JJ, Spoormans HH, Touw P, Werner FM, Grobbee DE,. Impact of anesthesia management characteristics on severe morbidity and mortality. Anesthesiology 2005; 102: 257-268.
6. Khuenl-Brady KS, Wattwil M, Vanacker BF, Lora-Tamayo JI, Rietbergen H, Alvarez-Gõmez JA,. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial. Anesth Analg 2010; 110: 64-73.
7. Blobner M, Eriksson LI, Scholz J, Motsch J, Della Rocca G, Prinsrsen ME,. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial. Eur J Anesthesia 2010; 27: 874-881.
8. Caldwell JE, Heier T, Wright PM, Lin S, McCarthy G, Szenohradszky J, Sharma ML, Hing JP, Schroeder M, Sessler DI,. Temperature-dependent pharmacokinetics and pharmacodynamics of vecuronium. Anesthesiology 2000; 92: 84-93.
9. Arain SR, Kern S, Ficke DJ, Ebert TJ,. Variability of duration of action of neuromuscular-blocking drugs in elderly patients. Acta Anaesthesiol Scand 2005; 49: 312-315.
10. Suy K, Morias K, Cammu G, Hans P, van Duijnhoven WGF, Heeringa M, Demeyer I,. Effective reversal of moderate rocuronium or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. Anesthesiology 2007; 106: 283-288.
11. Vanacker BF, Vermeyen KM, Struys MM, Rietbergen H, Vandermeersch E, Saldien V, Kalmar AF, Prins ME,. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane. Anesth Analg 2007; 104: 563-568.
12. Shields M, Giovannelli M, Mirakhur RK, Moppett I, Adams J, Hermens Y,. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block. Br J Anaesth 2006; 96: 36-43.
13. Fuchs-Burder T, Claudius C, Skovgaard LT, Eriksson LI, Mirakhur RK, Viby-Mogensen J,. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand 2007; 51: 789-808.
14. Vandenbroucke JP, Von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M, Initiative STROBE. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Gac Sanit 2009; 23: 158.
15. Berger ML, Dreyer N, Anderson F, Towse A, Sedrakyan A, Normand SL,. Prospective observational studies to assess comparative effectiveness: the ISPOR good research practices task force report. Value Health 2012; 15: 217-230.
16. Gaszynski T, Szewczyk T, Gaszynski W,. Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia. Br J Anaesth 2012; 108: 236-239.
17. Sacan O, White PF, Tufanogullari B, Klein K,. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine. Anesth Analg 2007; 104: 569-574.
18. Jones RK, Caldwell JE, Brull SJ, Soto RG,. Reversal of profound rocuronium-induced blockade with sugammadex. A randomized comparison with neostigmine. Anesthesiology 2008; 109: 816-824.
19. Geldner G, Niskanen M, Laurila P, Mizikov V, Hübler M, Beck G, Rietbergen H, Nicolayenko E,. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery. Anaesthesia 2012; 67: 991-998.
20. Schaller SJ, Fink H, Ulm K, Blobner M,. Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block. Anesthesiology 2010; 113: 1054-1060.
21. Sparr HJ, Vermeyen KM, Beaufort AM, Rietbergen H, Proost JH, Saldien V, Velik-Salchner C, Wierda JM,. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics. Anesthesiology 2007; 106: 935-943.
22. de Boer HD, Driessen JJ, Marcus MA, Kerkkamp H, Heeringa M, Klimek M,. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study. Anesthesiology 2007; 107: 239-244.
23. Groudine SB, Soto R, Lien C, Drover D, Roberts K,. A randomized, dose-finding, phase II study of the selective relaxant binding drug, Sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. Anesth Analg 2007; 104: 555-562.
24. Plaud B, Debaene B, Donati F, Marty J,. Residual paralysis after emergence from anesthesia. Anesthesiology 2010; 112: 1013-1022.
25. Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Marymont JH, Vender JS, Gray J, Landry E, Gupta DK,. Intraoperative acceleromyography monitoring reduces symptoms of muscle weakness and improves quality of recovery in the early postoperative period. Anesthesiology 2011; 115: 946-954.
26. Brull SJ, Murphy GS,. Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness. Anesth Analg 2010; 111: 129-140.